Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 878-888

  Kuhn, D M ^a   Chandra, J ^a   Mukherjee, P K ^a   Ghannoum, M A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCOFLUOR WHITE; CONCANAVALIN A ALEXAFLUOR 488; DYE; FUN 1; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; BIOFILM; BIOPROSTHESIS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEVICE; DRY WEIGHT; FLUORESCENCE MICROSCOPY; FUNGUS HYPHAE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; BIOFILMS; BIOPROSTHESIS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROSTHESIS-RELATED INFECTIONS; SILICONE ELASTOMERS; TIME FACTORS;

EID: 0036151240     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.2.878-888.2002     Document Type: Article

References (52)

1. Predictors of adverse outcome in cancer patients with candidemia
2. Candida biofilms and their susceptibility to antifungal agents
3. Role of dimorphism in the development of Candida albicans biofilms
4. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents
5. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989
6. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis
7. Sensitivity of biofilms to antimicrobial agents
8. Local macromolecule diffusion coefficients in structurally non-uniform bacterial biofilms using fluorescence recovery after photobleaching (FRAP)
9. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities in bacterial biofilms
10. Biofilm formation by the pathogen C. albicans-development, architecture, and drug resistance
11. Antifungal resistance of Candida biofilms formed on denture acrylic in vitro
12. Bacterial biofilms: A common cause of persistent infections
13. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture
14. Microbial biofilms: From ecology to molecular genetics
15. The involvement of cell-to-cell signals in the development of a bacterial biofilm
16. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: Their role and expression patterns
17. Factors influencing adherence of Candida spp. to host tissues and plastic surfaces
18. Bacterial alginate biosynthesis - Recent progress and future prospects
19. Production of extracellular matrix by Candida albicans biofilms
20. Biofilm formation by Candida species on the surface of catheter materials in vitro
21. Resistance of Candida albicans biofilms to antifungal agents in vitro
22. Binding of C. albicans to immobilized amino acids and bovine serum albumen
23. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents
24. The biofilm glycocalyx as a resistance factor
25. Longitudinal 10-year prospective survey of fungemia in the Slovak Republic: Trends in etiology in 310 episodes Slovak Fungaemic Group
26. Nosocomial candidemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution
27. Surface-induced and biofilm-induced changes in gene expression
28. Riddle of biofilm resistance
29. Mechanisms of biofilm resistance to antimicrobial agents
30. Guidelines for the management of intravascular catheter-related infections
31. Therapeutic approaches in patients with candidemia: Evaluation in a multicenter, prospective, observational study
32. Effect of serum concentration on Candida biofilm formation on acrylic surfaces
33. Biofilm formation as microbial development
34. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors, and outcome of 76 episodes
35. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
36. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis
37. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli
38. Attachment of Vibrio alginolyticus to chitin mediated by chitin-binding proteins
39. Practice guidelines for the treatment of candidiasis
40. Bakers' yeast, a model for fungal biofilm formation
41. Risk factors for candidemia in neonatal intensive care unit patients
42. Nosocomial acquisition of Candida parapsilosis: An epidemiologic study
43. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
44. Permeation of antimicrobial agents Pseudomonas aeruginosa biofilms: A simple method
45. Biofilm, city of microbes
46. A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor
47. Steps in the development of a Vibrio cholerae El Tor biofilm
48. Plasticizers increase adhesion of the deteriogenic fungus Aureobasidium pullulans to polyvinyl chloride
49. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers
50. Heterogeneity in biofilms
51. Measurement of polysaccharides and proteins in biofilm extracellular polymers